Fellowship · Baltimore, MD
Sponsored by Johns Hopkins University School of Medicine
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
The New England journal of medicine · 2023 · 1,343 citations · Kavita Sharma
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of Echocardiography.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2025 · 240 citations · Kavita Sharma
Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement.
Journal of the American College of Cardiology · 2023 · 576 citations · Kavita Sharma
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Lancet (London, England) · 2024 · 299 citations · Kavita Sharma
2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
Journal of the American College of Cardiology · 2023 · 423 citations · Gurusher Panjrath
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.
Circulation · 2024 · 205 citations · Nisha Gilotra
The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023 · 271 citations · Ryan Tedford
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Nature medicine · 2021 · 504 citations · Kavita Sharma